A new trading day began on Monday, with Geron Corp (NASDAQ: GERN) stock price down -5.19% from the previous day of trading, before settling in for the closing price of $1.35. GERN’s price has ranged from $1.09 to $4.50 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 5.60% over the last five years. Meanwhile, its annual earnings per share averaged 64.16%. With a float of $604.36 million, this company’s outstanding shares have now reached $637.85 million.
Geron Corp (GERN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 5.28%, while institutional ownership is 76.77%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 64.16% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Here are Geron Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.02 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Analysing the last 5-days average volume posted by the [Geron Corp, GERN], we can find that recorded value of 7.35 million was lower than the volume posted last year of 11.63 million. As of the previous 9 days, the stock’s Stochastic %D was 35.85%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 31.93%, which indicates a significant increase from 13.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0698 in the past 14 days, which was lower than the 0.0854 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3349, while its 200-day Moving Average is $1.7988. Now, the first resistance to watch is $1.3400. This is followed by the second major resistance level at $1.4000. The third major resistance level sits at $1.4350. If the price goes on to break the first support level at $1.2450, it is likely to go to the next support level at $1.2100. Should the price break the second support level, the third support level stands at $1.1500.
Geron Corp (NASDAQ: GERN) Key Stats
With a market capitalization of 816.66 million, the company has a total of 638,017K Shares Outstanding. Currently, annual sales are 76,990 K while annual income is -174,570 K. The company’s previous quarter sales were 49,040 K while its latest quarter income was -16,380 K.
